These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 14505357

  • 1. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B, Itzstein C, Delmas PD, Chenu C.
    J Cell Biochem; 2003 Oct 01; 90(2):424-36. PubMed ID: 14505357
    [Abstract] [Full Text] [Related]

  • 2. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 01; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 3. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 01; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 4. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 01; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 5. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 6. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH, Lee CK, Lee YI, Paik SG, Lee HJ.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):437-46. PubMed ID: 16083856
    [Abstract] [Full Text] [Related]

  • 7. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
    Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M.
    J Cell Biochem; 2004 May 15; 92(2):285-95. PubMed ID: 15108355
    [Abstract] [Full Text] [Related]

  • 8. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 15; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

  • 9. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul 15; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 10. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K.
    Biochem Biophys Res Commun; 2005 Mar 04; 328(1):91-7. PubMed ID: 15670755
    [Abstract] [Full Text] [Related]

  • 11. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
    Aitken CJ, Hodge JM, Nishinaka Y, Vaughan T, Yodoi J, Day CJ, Morrison NA, Nicholson GC.
    J Bone Miner Res; 2004 Dec 04; 19(12):2057-64. PubMed ID: 15537450
    [Abstract] [Full Text] [Related]

  • 12. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
    Yamaguchi M, Uchiyama S.
    Int J Mol Med; 2004 Jul 04; 14(1):81-5. PubMed ID: 15202020
    [Abstract] [Full Text] [Related]

  • 13. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.
    J Surg Res; 2001 Sep 13; 100(1):18-24. PubMed ID: 11516200
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 16. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.
    J Bone Miner Res; 2007 Oct 15; 22(10):1612-20. PubMed ID: 17576169
    [Abstract] [Full Text] [Related]

  • 17. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M, Amano S.
    J Bone Miner Metab; 2004 Oct 15; 22(5):415-29. PubMed ID: 15316862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF, Lie A, Ransjö M.
    J Cell Biochem; 2006 Oct 01; 99(2):528-37. PubMed ID: 16639710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.